数据链接：
官方服务：
资源简介：
TTO-stratified analysis of vosoritide-related AEs.
应用场景：
创建时间：
2026-01-29
相关数据集
Table_1_Morphological and Mechanical Properties of the Human Patella Tendon in Adult Males With Achondroplasia.pdf
Achondroplasia is a genetic mutation of fibroblast growth factor receptor resulting in impaired growth plate development in long bones due to lower collagen turnover. Despite the characteristic shorte
NIAID Data Ecosystem100
Treatment-related AEs of all grades reported by ≥10% of patients in either cohort (safety population) and treatment-related AEs of grade 3 and 4.
Treatment-related AEs of all grades reported by ≥10% of patients in either cohort (safety population) and treatment-related AEs of grade 3 and 4.
NIAID Data Ecosystem40
Supplementary Material for: The CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Clinical Outcomes in Untreated and Vosoritide-Treated Individuals
Introduction: Achondroplasia is a rare skeletal dysplasia characterized by severe disproportionate short stature. Vosoritide is currently the only approved therapy. The CrescNet registry is a network
Figshare2026-01-30 更新20
Risk ratio of fatal adverse events associated with mTOR inhibitors.
Abbreviations: RCC, renal cell cancer; BC, breast cancer; NET, neuroendocrine tumor.
NIAID Data Ecosystem60
Vital Signs Dataset in A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Pharmacodynamics of Sodium Nitroprusside During Prolonged Infusion in Pediatric Subjects
Height/length and weight, vital signs including pulse, blood pressure, and mean arterial pressure taken during open label and blinded study drug periods, and pulse and blood pressure within 30 minutes
NIAID Data Ecosystem20
